Lung Disease Complicates RA Care - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Lung Disease Complicates RA Care

Patients with chronic lung disease had numerically lower remission rates and substantially more serious adverse events in a 5-year Japanese registry study of late-onset rheumatoid arthritis.

  • By

  • Andrea Surnit

  • May 8, 2026

  • 4 min

Share

  • 1

    A treat-to-target strategy for late-onset rheumatoid arthritis is achievable but complicated by comorbidities and treatment limitations.

  • 2

    Patients with chronic lung disease had worse outcomes compared to those without, with 29.8% achieving remission versus 44.0%.

  • 3

    Serious adverse events occurred more frequently in patients with chronic lung disease, with an adjusted hazard ratio of 2.53.

  • 4

    Only 23 of 47 patients with chronic lung disease completed the study, highlighting significant attrition in this subgroup.

  • 5

    The study emphasizes the need for more evidence on managing chronic lung disease in rheumatoid arthritis treatment.

Original Source(s)

Lung Disease Complicates RA Care

  • by Andrea Surnit

  • May 8, 2026

Related Content

Joint Site May Influence RA Treatment Response

A Swiss registry study found that the wrist and second and third metacarpophalangeal joints consistently resolved more slowly than most other joints following biologic or targeted synthetic therapy.

Trial Exclusions May Skew RA Drug Comparisons

Nearly 40% of registry patients would have been excluded from phase 3 randomized controlled trials, with exclusion criteria distributed unevenly across drug classes.

JAK Monotherapy Shows Efficacy in RA Review

A systematic review found Janus kinase inhibitor monotherapy improved outcomes vs methotrexate or placebo, but direct comparisons with combination therapy were limited.